What happened
HLB Therapeutics updated a previously disclosed supply contract with the Public Procurement Service, now worth US$2.59M, about 7.29% of its recent annual revenue.
For context, this single contract equals about 7.29% of the company's most recent annual revenue.
| Counterparty | the Public Procurement Service |
|---|---|
| Contract value | US$2.59M |
| vs. recent revenue | 7.29% |
| Through | N/A |
| Filed | 2026-06-30, [Amended] Supply contract signed |
| Source | DART rcept 20260630901334 → open original filing |
Source: DART. Information only, not investment advice.